What is LOPJLB’s current signal on IDYA?

LOPJLB’s latest quantitative signal on IDEAYA Biosciences, Inc. (IDYA) is SELL in a BEAR regime. Signals are updated daily.

What market regime is IDYA in?

IDEAYA Biosciences, Inc. (IDYA) is currently classified in the BEAR HMM market regime on LOPJLB.

What does IDEAYA Biosciences, Inc. (IDYA) do?

IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs. IDE397, a methionine adenosy…

Where is IDEAYA Biosciences, Inc. based / listed?

IDEAYA Biosciences, Inc. is based in US, listed on NASDAQ.

IDEAYA Biosciences, Inc. (IDYA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$36.11+0.14%Close

SELLBEAR · day 20

[SCORES & PROFILE]

FUND: 4
VALUE: 6
GROWTH: 8
GARP: 4
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-9.9%

REV YoY-

ROE-16.5%

EPS YoY-

ROA-13.4%

GROSS

-13

-93

NET

-75

[VALUATION]

P/E TTM-19.08

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B2.81

P/FCF-

EV/EBITDA-15.25

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E2.44

ALTMAN Z-

CURR RATIO10.45

ND/EBITDA-

BETA-0.09

IDEAYA Biosciences, Inc. (IDYA)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news